共 50 条
- [42] A 4-year survey on palivizumab respiratory syncytial virus (RSV)-prophylaxis: How can compliance be improved? JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2006, 19 (04): : 221 - 224
- [43] A comparative study of respiratory syncytial virus (RSV) prophylaxis in premature infants within the Canadian Registry of Palivizumab (CARESS) European Journal of Clinical Microbiology & Infectious Diseases, 2012, 31 : 2703 - 2711
- [46] Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2012, 1
- [48] Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use Antimicrobial Resistance and Infection Control, 1
- [50] Palivizumab - the humanised monoclonal antibody for prevention of respiratory syncytial virus (RSV) infection ZEITSCHRIFT FUR GEBURTSHILFE UND NEONATOLOGIE, 2000, 204 (03): : 120 - 122